Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1007/s10803-017-3153-x) contains supplementary material, which is available to authorized users.
The members of ADDIRC are listed in Acknowledgments section.
Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Supplementary material 1 (DOCX 12 KB)10803_2017_3153_MOESM1_ESM.docx
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 5, 485–491.
Christensen, D. L. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years- autism developmental disabilities monitoring network. Surveillance Summaries 65.
King, B. H., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66, 583–590. doi: 10.1001/archgenpsychiatry.2009.30. CrossRefPubMedPubMedCentral
Lord, C., Rutter, M., DiLavore, P., Risis, S., Gotham, K., & Bishop, S. (2012). Autism diagnostic observation schedule, second edition (ADOS-2). Torrance: Western Psychological Services.
Marcus, R. N., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110–1119. doi: 10.1097/CHI.0b013e3181b76658. CrossRefPubMedPubMedCentral
Roid, G. H., Miller, L. J., Pomplun, M., Koch, C. (2013). Leiter international performance scale, 3rd Edition. Wood Dail, IL: Stoelting.
Rutter, M., Bailey, A., Lord, C. (2003). Social communication questionnaire. Torrance: Western Psychological Services.
Sparrow, S., Cicchetti, D., Balla, D.A. (2008). Vineland adaptive behaviors scales, 2nd Edition. Livonia: Pearson.
- Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder
Logan K. Wink
Ernest V. Pedapati
Craig A. Erickson
Kahsi A. Pedersen
Eric M. Morrow
for the Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC)
- Springer US